CareLit · DOI-Nachweis · Aktuelle Neurologie
Immunoglobulines in the treatment of multiple sclerosis after failure or intolerability of licensed therapies – results of a retrospective multicentre observational study
DOI 10.1055/s-2006-953226
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM. Bauer, S. Kremer
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The efficacy of IVIG in the treatment of patients with multiple sclerosis (MS) is still under discussion. Despite evidence from clinical trials and daily practice available data are seen as insufficient to license intravenous immunoglobulines for treatment of relapsing-remitting multiple sclerosis (RR-MS). However according to national and international consensus IVIG are proposed as second line therapy in case of i…
Zitieren
Zitierempfehlung
M. Bauer, S. Kremer (2006) Immunoglobulines in the treatment of multiple sclerosis after failure or intolerability of licensed therapies – results of a retrospective multicentre observational study. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953226
Mit CareLit weiterarbeiten